Primary Record
RANOLAZINE
- In stock
- 1,531 g
- Purity
- 99.0 %
- CAS
- 95635-55-5
Compound Identifiers & Properties
- CAS
- 95635-55-5
- PubChem CID
- 56959
- SMILES
- CC1=C(C(=CC=C1)C)NC(=O)CN2CCN(CC2)CC(COC3=CC=CC=C3OC)O
- Canonical SMILES
- COc1ccccc1OCC(O)CN1CCN(CC(=O)Nc2c(C)cccc2C)CC1
Names & Synonyms
- RANOLAZINE
- Ranexa
- 95635-55-5
- renolazine
- Ran4
- Ranolazina
- Latixa
- Ranolazine dihydrochloride
- Ranolazine 2HCl
- metoprolol
- ranolazinum
- renexa
- RAN D
- Ranolazine 1g
- Ranolazine-d3
- (-)-Ranolazine
- Ranolazin
- Ranolazine-D8
- (+-)-Ranolazine
- Ranolazine HCl
- ASPRUZYO
- HCl, Ranolazine
- (R)-ranolazine
- CVT-303
- Ranexa (TN)
- Ranolazine [USAN]
- Ranexa, Ranolazine
- ( -)-Ranolazine
- Ranolazine (Ranexa)
- (+/-)-Ranolazine
- Ranolazine (Ranexa)?
- Ranolazine (Standard)
- Ranolazine (USAN/INN)
- Ranolazine hydrochloride
- RANOLAZINE 5G
- ASPRUZYO SPRINKLE
- RANOLAZINE [MI]
- RefChem:55969
- AC1Q5LYD
- Hydrochloride, Ranolazine
- RANOLAZINE [INN]
- N-(2,6-dimethylphenyl)-2-(4-(2-hydroxy-3-(2-methoxyphenoxy)propyl)piperazin-1-yl)acetamide
- A6IEZ5M406
- GlyTouCan:G17204EU
- UNII-A6IEZ5M406
- C24H33N3O4
- DTXSID3045196
- RANOLAZINE [VANDF]
- D03HYQ
- D06TES
- Dihydrochloride, Ranolazine
- Ranolazine [USAN:INN:BAN]
- RANOLAZINE [MART.]
- CHEMBL1404
- RANOLAZINE [USP-RS]
- RANOLAZINE [WHO-DD]
- Lopac0_001062
- MFCD00864690
- BSPBio_002276
- DTXCID1025196
- RS-43285-003
- CHEBI:87690
- HSDB 7924
- MLS002154149
- NSC-759100
- RANOLAZINE [EMA EPAR]
- SCHEMBL124665
- SPECTRUM1505366
- CVT 303
- XKLMZUWKNUAPSZ-UHFFFAOYSA-N
- AC1L1M17
- GTPL7291
- N-(2,6-dimethylphenyl)-2-[4-[2-hydroxy-3-(2-methoxyphenoxy)propyl]piperazin-1-yl]acetamide
- orb1300599
- Ranolazine - Bio-X trade mark
- SCHEMBL7933344
- 142387-99-3
- KEG-1295
- RANOLAZINE [ORANGE BOOK]
- RS-43285
- CHEBI:87681
- CTK3I7295
- ERK5-3F22
- HY-B0280R
- C01EB18
- GLXC-07953
- HMS1922F16
- HMS2090L09
- HMS2093D21
- HMS2098K06
- HMS2230C19
- HMS3369I08
- HMS3655M12
- HMS3715K06
- HMS3884I10
- HMS5080E09
- Pharmakon1600-01505366
- ACT06286
- AMY14177
- BCP04190
- CID56959
- G17204EU
- HY-B0280
- KS-00000JS7
- PEA24680
- RS43285
- SFA38799
- STB80488
- sodium 3,5-dicarboxybenzenesulfonate
- Tox21_110258
- BDBM50173335
- CR0012
- EBC-11221
- NCGC00015897-02
- NP3430
- NSC759100
- NSC782305
- s1799
- AKOS015889500
- C24-H33-N3-O4
- Tox21_110258_1
- AC-1673
- AN-5494
- BCP9000558
- CCG-205139
- CS-2292
- DB00243
- FD61499
- KS-1244
- NSC 759100
- NSC-782305
- PB21724
- SB13209
- SDCCGSBI-0051032.P003
- N-(2,6-dimethylphenyl)-2-{4-[2-hydroxy-3-(2-methoxyphenoxy)propyl]piperazin-1-yl}acetamide
- NCGC00015897-03
- NCGC00015897-04
- NCGC00015897-05
- NCGC00015897-06
- NCGC00015897-08
- NCGC00015897-22
- NCGC00095177-01
- NCGC00095177-02
- NCGC00095177-03
- 4CA-1078
- AK-72950
- BC205445
- BD164322
- BR-72950
- H959
- RS 43285
- SC-25810
- SMR000857382
- BCP0726000090
- SBI-0051032.P002
- 43285, RS
- AB0007809
- AB2000299
- CAS-95635-55-5
- LS-187267
- TR-031802
- 2451B
- NS00002495
- Ranolazine/Dronedarone Fixed-Dose Combination
- ST24025536
- SW197620-4
- CVT 303;RS 43285-003
- J3.066.456F
- RS 43285193
- A11162
- D05700
- EN300-122384
- RS 43285 193
- RS 43285-003
- RS 43285-193
- S-1794
- 95635-56-6
- AB00698532-11
- AB00698532-13
- AB00698532-14
- AB00698532-15
- AB00698532_16
- AB00698532_17
- AB00698532_18
- 635R555
- C055512
- F079440
- Q907104
- SR-01000076216
- I01-2008
- I06-0160
- SR-01000076216-5
- SR-01000076216-8
- BRD-A97674275-001-01-9
- BRD-A97674275-001-04-3
- BRD-A97674275-001-10-0
- BRD-A97674275-001-11-8
- BRD-A97674275-300-03-1
- N-(2,6-DIMETHYLPHENYL)-4-[2-HYDROXY-3-(2-METHOXYPHENOXY)PROPYL]-1-PIPERAZINEACETAMIDE
- Z68563450
- N-(2,6-dimethylphenyl)-4-(2-hydroxy-3-(2-methoxyphenoxy)propyl)-1-piperazineacetamide
- Ranolazine Working Standard (Secondary Reference Standard)
- 1-Piperazineacetamide, N-(2,6-dimethylphenyl)-4-(2-hydroxy-3-(2-methoxyphenoxy)propyl)-
- 1-Piperazineacetamide, N-(2,6-dimethylphenyl)-4-[2-hydroxy-3-(2-methoxyphenoxy)propyl]-
- 1092804-88-0
- (+-)-4-[2-hydroxy-3-(o-methoxyphenoxy)propyl]-1-piperazineaceto-2',6'-xylidide
- (+/-)-4-(2-Hydroxy-3-(o-methoxyphenoxy)propyl)-1-piperazineaceto-2',6'-xylidide
- (+-)-N-(2,6-Dimethylphenyl)-4-(2-hydroxy-3-(2-methoxyphenoxy)propyl)-1-piperazineacetamide
- (+/-)-1-(3-(2-Methoxyphenoxy)-2-hydroxypropyl)-4-(n-(2,6-dimethylphenyl)carbamoylmethyl)piperazine
- (+/-)-N-(2,6-DIMETHYLPHENYL)-4-(2-HYDROXY-3-(2-METHOXYPHENOXY)PROPYL)-1-PIPERAZINEACETAMIDE
- 1-[3-(2-methoxyphenoxy)-2-hydroxypropyl]-4-[(2,6-dimethylphenyl)aminocarbonylmethyl]piperazine
- 1-Piperazineacetamide, N-(2,6-dimethylphenyl)-4-(2-hydroxy-3-(2-methoxyphenoxy)propyl)-, (+-)-
- 1-Piperazineacetamide, N-(2,6-dimethylphenyl)-4-[2-hydroxy-3-(2-methoxyphenoxy)propyl]-, (+/-)-
- 1054624-77-9
- 1080496-58-7
- 110445-25-5
- 114246-80-9
- 37350-58-6
- N-(2,6-Dimethyl-phenyl)-2-{4-[2-hydroxy-3-(2-methoxy-phenoxy)-propyl]-piperazin-1-yl}-acetamide
- N-(2,6-DIMETHYLPHENYL)-2-(4-((2RS)-2-HYDROXY-3-(2-METHOXYPHENOXY)PROPYL)PIPERAZIN-1-YL)ACETAMIDE
- N-(2,6-Dimethylphenyl)-2-(4-(2-hydroxy-3-(2-methoxy-phenoxy)propyl)piperazin-1-yl)acetamide
- N-(2,6-dimethylphenyl)-2-(4-(2-hydroxy-3-(2-methoxyphenoxy)propyl)piperazin-1-yl)ethanimidic acid
- N-(2,6-Dimethylphenyl)-2-{4-[2-hydroxy-3-(2-methoxyphenoxy)-propyl]piperazin-1-yl}-acetamide
- N-(2,6-dimethylphenyl)-2-{4-[2-hydroxy-3-(2-methoxyphenoxy)propyl]piperazin-1-yl}ethanimidic acid
- N-(2,6-Dimethylphenyl)-4-[2-hydroxy-3-(2-methoxyphenoxy)propyl]-1-piperazineacetamide; CVT 303; RS 43285-003; Ranexa; Ranolazine; Renexa; 1-Piperazineacetamide, N-(2,6-dimethylphenyl)-4-[2-hydroxy-3-(2-methoxyphenoxy)propyl]-, (+/-)-; (+/-)-Ranolazine